sanofi-aventis U.S. LLC.
Sanofi-aventis U.S. LLC. (Sanofi-aventis) is engaged in the discovery, development , manufacture and marketing of innovative pharmaceutical therapies. It has major focus in key therapeutic areas of cardiology, oncology and internal medicine, metabolic diseases, central nervous system disorders and vaccines. The company's research sites in US are located at New Jersey, Pennsylvania, Massachusetts, and Arizona. Its key products portfolio includes Ambien CR (zolpidem tartrate extended release) CIV, Eloxatin (oxaliplatin injection), Lantus (insulin glargine [rDNA origin] injection), Lovenox (enoxaparin sodium injection),Plavix (clopidogrel bisulfate) and Taxotere (docetaxel) Injection Concentrate. The company is also a full-service pharmaceutical contract packager and provides packing services for prescription products, over-the-counter medications, and other promotional/secondary packaging. The company is headquartered at New Jersey, the US.